[Two cases of conjunctival malignant melanoma treated with topical interferon alpha-2b drop as an adjuvant therapy].

Satoru Kase, Kan Ishijima, Mika Noda, Susumu Ishida

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Topical interferon alpha-2b (IFNalpha-2b) eye drops suppress tumor growth through the activation of host immunity on the ocular surface. Conjunctival malignant melanoma, a rare malignant tumor in Japan, develops local recurrence and lymph node metastasis. We herein report two cases with conjunctival melanoma treated with topical IFNalpha-2b eye drops. Case 1, a 77-year-old woman presented with temporal conjunctival pigmented nodules, simulating primary acquired melanosis (PAM) on the cornea and around the conjunctiva OD. Case 2, an 84-year-old woman, presented with nasal conjunctival pigmented nodules and PAM OD. Both patients underwent tumor excision and IFNalpha-2b drops four times per day for half a year. Histologically, the excised conjunctival nodules of both patients were diagnosed with malignant melanoma. There was no local recurrence or distant metastasis 24 months after tumor resection. Topical IFNa-2b is a useful adjuvant treatment in patients with conjunctival malignant melanoma, following tumor resection.

Original languageEnglish
Pages (from-to)1043-1047
Number of pages5
JournalNihon Ganka Gakkai zasshi
Volume115
Issue number11
Publication statusPublished - 2011 Nov
Externally publishedYes

Fingerprint

interferon alfa-2b
Melanoma
Melanosis
Ophthalmic Solutions
Neoplasms
Neoplasm Metastasis
Therapeutics
Recurrence
Conjunctiva
Nose
Cornea
Immunity
Japan
Lymph Nodes

ASJC Scopus subject areas

  • Ophthalmology

Cite this

[Two cases of conjunctival malignant melanoma treated with topical interferon alpha-2b drop as an adjuvant therapy]. / Kase, Satoru; Ishijima, Kan; Noda, Mika; Ishida, Susumu.

In: Nihon Ganka Gakkai zasshi, Vol. 115, No. 11, 11.2011, p. 1043-1047.

Research output: Contribution to journalArticle

Kase, Satoru ; Ishijima, Kan ; Noda, Mika ; Ishida, Susumu. / [Two cases of conjunctival malignant melanoma treated with topical interferon alpha-2b drop as an adjuvant therapy]. In: Nihon Ganka Gakkai zasshi. 2011 ; Vol. 115, No. 11. pp. 1043-1047.
@article{c7897b60c9954fbfb091a28361997a27,
title = "[Two cases of conjunctival malignant melanoma treated with topical interferon alpha-2b drop as an adjuvant therapy].",
abstract = "Topical interferon alpha-2b (IFNalpha-2b) eye drops suppress tumor growth through the activation of host immunity on the ocular surface. Conjunctival malignant melanoma, a rare malignant tumor in Japan, develops local recurrence and lymph node metastasis. We herein report two cases with conjunctival melanoma treated with topical IFNalpha-2b eye drops. Case 1, a 77-year-old woman presented with temporal conjunctival pigmented nodules, simulating primary acquired melanosis (PAM) on the cornea and around the conjunctiva OD. Case 2, an 84-year-old woman, presented with nasal conjunctival pigmented nodules and PAM OD. Both patients underwent tumor excision and IFNalpha-2b drops four times per day for half a year. Histologically, the excised conjunctival nodules of both patients were diagnosed with malignant melanoma. There was no local recurrence or distant metastasis 24 months after tumor resection. Topical IFNa-2b is a useful adjuvant treatment in patients with conjunctival malignant melanoma, following tumor resection.",
author = "Satoru Kase and Kan Ishijima and Mika Noda and Susumu Ishida",
year = "2011",
month = "11",
language = "English",
volume = "115",
pages = "1043--1047",
journal = "Nippon Ganka Gakkai zasshi",
issn = "0029-0203",
publisher = "Nippon Ganka Gakkai",
number = "11",

}

TY - JOUR

T1 - [Two cases of conjunctival malignant melanoma treated with topical interferon alpha-2b drop as an adjuvant therapy].

AU - Kase, Satoru

AU - Ishijima, Kan

AU - Noda, Mika

AU - Ishida, Susumu

PY - 2011/11

Y1 - 2011/11

N2 - Topical interferon alpha-2b (IFNalpha-2b) eye drops suppress tumor growth through the activation of host immunity on the ocular surface. Conjunctival malignant melanoma, a rare malignant tumor in Japan, develops local recurrence and lymph node metastasis. We herein report two cases with conjunctival melanoma treated with topical IFNalpha-2b eye drops. Case 1, a 77-year-old woman presented with temporal conjunctival pigmented nodules, simulating primary acquired melanosis (PAM) on the cornea and around the conjunctiva OD. Case 2, an 84-year-old woman, presented with nasal conjunctival pigmented nodules and PAM OD. Both patients underwent tumor excision and IFNalpha-2b drops four times per day for half a year. Histologically, the excised conjunctival nodules of both patients were diagnosed with malignant melanoma. There was no local recurrence or distant metastasis 24 months after tumor resection. Topical IFNa-2b is a useful adjuvant treatment in patients with conjunctival malignant melanoma, following tumor resection.

AB - Topical interferon alpha-2b (IFNalpha-2b) eye drops suppress tumor growth through the activation of host immunity on the ocular surface. Conjunctival malignant melanoma, a rare malignant tumor in Japan, develops local recurrence and lymph node metastasis. We herein report two cases with conjunctival melanoma treated with topical IFNalpha-2b eye drops. Case 1, a 77-year-old woman presented with temporal conjunctival pigmented nodules, simulating primary acquired melanosis (PAM) on the cornea and around the conjunctiva OD. Case 2, an 84-year-old woman, presented with nasal conjunctival pigmented nodules and PAM OD. Both patients underwent tumor excision and IFNalpha-2b drops four times per day for half a year. Histologically, the excised conjunctival nodules of both patients were diagnosed with malignant melanoma. There was no local recurrence or distant metastasis 24 months after tumor resection. Topical IFNa-2b is a useful adjuvant treatment in patients with conjunctival malignant melanoma, following tumor resection.

UR - http://www.scopus.com/inward/record.url?scp=84855546642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855546642&partnerID=8YFLogxK

M3 - Article

VL - 115

SP - 1043

EP - 1047

JO - Nippon Ganka Gakkai zasshi

JF - Nippon Ganka Gakkai zasshi

SN - 0029-0203

IS - 11

ER -